Bms Financial Advisors, LLC Astrazeneca PLC Transaction History
Bms Financial Advisors, LLC
- $148 Million
- Q2 2023
A detailed history of Bms Financial Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Bms Financial Advisors, LLC holds 5,586 shares of AZN stock, worth $432,021. This represents 0.27% of its overall portfolio holdings.
Number of Shares
5,586
Previous 7,872
29.04%
Holding current value
$432,021
Previous $546,000
26.92%
% of portfolio
0.27%
Previous 0.38%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,248Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.74 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.8 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.32 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.67 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.34 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...